The Use of Differential Scanning Calorimetry to Study Drug-Membrane Interactions
Time of Update: 2021-01-04
Differential-scanning calorimetry is a useful technique to study the interdigitation effect of a drug by monitoring Δ H changes.
An in vitro transcription assay for probing drug-DNA interactions at individual drug sites
Time of Update: 2020-11-21
An in vitro transcription assay of drug- DNA interactions has been described and is based largely on the stable lac UV5-initiated transcription complex.
Zhengzhou University has found that releasing large amounts of calcium ions can kill drug-resistant tumor cells
Time of Update: 2020-11-12
now, in a new study, researchers from Zhengzhou University in China have developed nanoparticles that release large amounts of calcium ions in tumor cells, inhibit drug pumps and reverse multidrrupable resistance.
New drug for idempable narcolepsy! Unique cation hydroxybutyric acid therapy Xywav (calcium
Time of Update: 2020-10-23
Oct 11, 2020 // -- Jazz Pharmaceuticals recently announced positive top-line results for evaluating Xywav (sodium hydroxybutyrate, potassium, magnesium, calcium, JZP-258) oral solution for the treatment of idiopathic hypersomnia (IH) adult patients.
New anti-inflammatory drugs! Bronger Ingeham terminates clinical development of AOC3 inhibitor BI1467335: there is a risk of drug interaction!
Time of Update: 2020-09-27
September 08, 2020 // -- Boehringer Ingelheim and Pharmaxis recently jointly announced the termination of the development of BI1467335 for the treatment of moderate to non-proliferative diabetic retinal lesions (NPDR).
The meeting previewed I "drug combustion" Kaidong - 2020 biopharmaceutical production and integration interactive forum.
Time of Update: 2020-09-05
Contractors: Kaidong High-tech Industrial Development Zone Management Committee, Wise Pharmaceutical Jiangsu Co., Ltd., Huaxing Capital Holdings Co., Ltd., Fahrenheit Kangyuan Pharmaceutical Technology Co., Ltd. Co-technology Media: Easy Enterprise
Ten billion-level heavyweight varieties piled up the stone drug "Imatimi", Jingxin "Pivastatin calcium":
Time of Update: 2020-08-02
, and 13 varieties were accepted ... Reviewed the details of 4 varieties have been reviewed, stone drug European "Imatini" this week listed 4 varieties through consistency evaluation, of which 2 varieties are the first, for Zhejiang Jing new drug
New drugs for extra-use of plaque-type psoriasis! FDA approves Wynzora (calcium poisol/ dipropyl acid fentamisopine) cream!
Time of Update: 2020-07-31
treatment of plaque-like psoriasis. Wynzora cream is based on PAD technology, which uniquely makes calcium pometriphyand and dipropyosulprate thin rice pine stable in water-based formulations that are easy to use. Phase III trials conducted
First lupus nephritis (LN) drug! The new best-in-class calcium-modulating neurophosphatase inhibitor voclosporin has been reviewed by the FDA!
Time of Update: 2020-07-28
Structure (Picture Source: Company) is a research drug which is a new, potentially best-in-class () calcium-modulating neurophosphosase inhibitor () with clinical data on multiple indications than in patients.
Lysine phosphate calcium: to inform a batch of illegal and serious drug advertising
Time of Update: 2020-07-03
Xinhua, Jinan, August 1 (Reporter Wang Yani) Shandong Province Food and Drug Administration recently informed a number of serious illegal drug advertising, to remind patients to pay attention to identification.
Calcium-mucoprotein-mediated intercellular interaction regulates the iron death mechanism of cancer cells
Time of Update: 2020-06-08
original title: Calcium-mucoprotein-mediated intercellular interaction regulates the iron death mechanism of cancer cells
First lupus nephritis (LN) drug! New best-in-class calcium-toned neurophosphospresse inhibitor voclosporin is available in the United States!
Time of Update: 2020-05-28
, Aurinia has successfully completed a Phase III clinical study (AURORA) on voclosporin's treatment of lupus nephritis.
(Interactive) Botten shares: 108 workshop can produce innovative drug GMP intermediates
Time of Update: 2020-05-13
(Interactive) Botten shares : 108 workshop can produce new drugs GMP intermediates source: Panorama author: 2014-08-19 23:20:15 font: CICC Online Weibo WeChat plus
Sodium calcium glass infusion bottle son 3 batches of "drug package material" sampling is not qualified
Time of Update: 2020-04-14
Recently, Shandong Provincial Drug Administration issued a "drug package material" quality supervision and sampling notice, according to the 2019 Shandong Province drug package material quality supervision and sampling work plan, Shandong
New China Pharmaceutical 3.1 special constipation drug polycarboxylate calcium has been approved
Time of Update: 2020-04-03
According to the information on June 9 on the website of the State Food and Drug Administration (CFDA), the evaluation status of new China Pharmaceutical's special drug
The three kinds of clinical drugs, nifedipine citrate and alfatinib maleate, applied by Shiyao group were accepted
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on May 26, two kinds of three kinds of drugs applied for clinical application by Shiyao group, i.e
Xinhua Pharmaceutical class 3.1 constipation treatment drug polycarboxylate non calcium completed the on-site inspection
Time of Update: 2020-04-03
According to the website of the State Food and Drug Administration (CFDA) on April 2, on-site inspection has been completed for polycarbonate non calcium tablets and APIs, a class
The third one in China: Lu Kang medicine received the approval for drug registration of calcium acetate granules
Time of Update: 2020-01-13
On January 11, Lu Kang medicine announced that it had received the approval document for drug registration of calcium acetate granules issued by the State Food and drug
Atorvastatin calcium drug store less than 2 yuan? A large number of commonly used drugs need to be reduced in price
Time of Update: 2019-11-17
Therefore, it can be affirmed that the state is unswervingly committed to the task of reducing drug prices, and will only vigorously carry out the reform of centralized procurement of drug consumables.
Jingxin pharmaceutical: rosuvastatin calcium dispersible tablets obtained the approval of drug registration
Time of Update: 2019-05-16
On May 15, Beijing New Pharmaceutical Co., Ltd
issued an enterprise announcement, saying that its company has received the registration approval document of rosuvastatin